Leadiant Biosciences recalls
Leadiant Biosciences has 4 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 22 Feb 2023. The most frequent reason is potency & assay.
Total recalls4since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 22 Feb 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 25%Class III 3 75%
Why leadiant biosciences is recalled
Product types
By year
All leadiant biosciences recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL recalled | Leadiant Biosciences | Sterility | Nationwide |
| Drug | CLASS III | Cystaran (cysteamine ophthalmic solution) recalledCystaran | Leadiant Biosciences | Potency & Assay | PA |
| Drug | CLASS III | Cystaran (cysteamine ophthalmic solution) recalledCystaran | Leadiant Biosciences | Potency & Assay | PA |
| Drug | CLASS III | Cystaran (cysteamine ophthalmic solution) recalledCystaran | Leadiant Biosciences | Potency & Assay | PA |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.